These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7388693)

  • 1. beta-Endorphin-induced prolactin secretion is mediated by suppression of release of newly synthesized hypothalamic dopamine.
    Van Loon GR; De Souza EB; Ho D; Shin SH
    Can J Physiol Pharmacol; 1980 Apr; 58(4):436-9. PubMed ID: 7388693
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-endorphin-induced decrease in hypothalamic dopamine turnover.
    van Loon GR; Ho D; Kim C
    Endocrinology; 1980 Jan; 106(1):76-80. PubMed ID: 7349975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release and synthesis rates of catecholamines in hypothalamic, limbic and midbrain structures following intraventricular injection of beta-endorphin in male rats.
    Lohse M; Wuttke W
    Brain Res; 1981 Dec; 229(2):389-402. PubMed ID: 6272941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-opiate beta-endorphin fragments and dopamine-V. gamma-Type endorphins and prolactin secretion in rats.
    Lamberts SW; de Quijada M; Van Ree JM; De Wied D
    Neuropharmacology; 1982 Nov; 21(11):1129-35. PubMed ID: 6184642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic mediation of beta-endorphin-induced prolactin secretion.
    Van Loon GR; De Souza EB; Shin SH
    Neuroendocrinology; 1980 Oct; 31(4):293-6. PubMed ID: 6252497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by lithium of dopamine receptors in rat prolactin release.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1981 Nov; 223(2):335-42. PubMed ID: 6269703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site of action for beta-endorphin-induced changes in plasma luteinizing hormone and prolactin in the ovariectomized rat.
    Wiesner JB; Koenig JI; Krulich L; Moss RL
    Life Sci; 1984 Apr; 34(15):1463-73. PubMed ID: 6323905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by morphine and beta-endorphin of vasopressin release evoked by electrical stimulation of the rat medial basal hypothalamus in vitro.
    Knepel W; Reimann W
    Brain Res; 1982 Apr; 238(2):484-8. PubMed ID: 6284302
    [No Abstract]   [Full Text] [Related]  

  • 9. beta-Endorphin alters dopamine uptake by the dopamine neurons of the hypothalamus and striatum.
    George SR; Van Loon GR
    Brain Res; 1982 Sep; 248(2):293-303. PubMed ID: 6291701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid peptides in the regulation of TSH and prolactin secretion in the rat.
    Rauhala P; Tuominen RK; Männistö PT
    Acta Endocrinol (Copenh); 1987 Mar; 114(3):383-8. PubMed ID: 2951956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of beta-endorphin fragment 6-31 on morphine- and beta-endorphin-induced growth hormone and prolactin release.
    Panerai AE; Cocchi D; Parenti M; Martini A; Mantegazza P; Li CH
    Eur J Pharmacol; 1984 Apr; 99(4):341-3. PubMed ID: 6329787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of beta-endorphin on catecholamine levels in the rat hypothalamus and cerebral cortex].
    Slavnov VN; Valueva GV; Markov VV; Luchitskiĭ EV
    Biull Eksp Biol Med; 1986 May; 101(5):562-4. PubMed ID: 2939890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturation of the prolactin and proopiomelanocortin-derived peptide responses to ether stress and morphine: neurochemical analysis.
    Johnston CA; Negro-Vilar A
    Endocrinology; 1986 Feb; 118(2):797-804. PubMed ID: 3002767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic and opioid compounds. Effects on prolactin and LH release after electrical stimulation of the hypothalamus in ovariectomized rhesus monkeys.
    Spies HG; Quadri SK; Chappel SC; Norman RL
    Neuroendocrinology; 1980 Apr; 30(4):249-56. PubMed ID: 6769067
    [No Abstract]   [Full Text] [Related]  

  • 15. The beta-endorphin-induced secretion of growth hormone but not of prolactin is inhibited by an endogenous opioid antagonist.
    Collado-Escobar D; Rovati LC; Ganzetti I; Cocchi D; Panerai AE; Li CH
    Eur J Pharmacol; 1986 Oct; 129(3):385-7. PubMed ID: 2946593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of catecholamine turnover rates in limbic and hypothalamic structures in relation to serum prolactin and gonadotropin levels.
    Höhn KG; Wuttke W
    Brain Res; 1979 Dec; 179(2):281-93. PubMed ID: 574418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholestrogens affect catecholamine turnover rates in the anterior part of the mediobasal hypothalamus and medial preoptic area in the male and female castrated rat.
    Parvizi N; Wuttke W
    Neuroendocrinology; 1983; 36(1):21-6. PubMed ID: 6828204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction by beta-endorphin of efflux of dopamine and DOPAC from superfused medial basal hypothalamus.
    Wilkes MM; Yen SS
    Life Sci; 1980 Oct; 27(15):1387-91. PubMed ID: 6255276
    [No Abstract]   [Full Text] [Related]  

  • 19. Supersensitivity of anterior pituitary dopamine receptors involved in the inhibition of prolactin secretion following destruction of the medial basal hypothalamus.
    Cheung CY; Weiner RI
    Endocrinology; 1976 Sep; 99(3):914-7. PubMed ID: 954677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial study on the possible mechanisms involved in the effects of high doses of perfluorooctane sulfonate (PFOS) on prolactin secretion.
    Salgado R; Pereiro N; López-Doval S; Lafuente A
    Food Chem Toxicol; 2015 Sep; 83():10-6. PubMed ID: 26032630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.